Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Omada Health, Inc. (OMDA)

Omada Health Q3 revenue rises 34% to $91 million; raises 2026 revenue and EBITDA outlook

Positive Impact 4 of 5 earnings Written later

Omada Health reported third quarter 2026 results, with revenue of $91 million, up from $68 million a year earlier, and net income of $7 million compared with a net loss of $3 million in Q3 2025. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, which should matter to shareholders because both headline measures moved up from the prior outlook.

Key points

  • Q3 2026 revenue of $91 million, up 34% from $68 million in Q3 2025
  • Net income of $7 million, compared with a net loss of $3 million in Q3 2025
  • Full-year 2026 revenue guidance raised to $344 million to $346 million from $334 million to $340 million
  • Full-year 2026 adjusted EBITDA guidance raised to $32 million to $34 million from $21 million to $27 million

The filing

CompanyOmada Health, Inc. (OMDA)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:01 PM ET
Accession number0001628280-26-070989

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.